Regeneron Pharmaceuticals (REGN) P/E Ratio
Regeneron Pharmaceuticals (REGN) reported P/E ratio of 18.6× in fiscal 2025. The high over this period was 25.3×, in fiscal 2023.
Free: last 5 years
| Fiscal year | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 8.8× | 18.9× | 25.3× | 18.6× | 18.6× |